Suppr超能文献

非特异性斑秃患者的血清白细胞介素-4和总免疫球蛋白E及HLA-DRB1分型

Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

作者信息

Attia Enas A S, El Shennawy Dina, Sefin Ashraf

机构信息

Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.

出版信息

Dermatol Res Pract. 2010;2010:503587. doi: 10.1155/2010/503587. Epub 2010 Jun 30.

Abstract

Background. Interleukin-4 (IL-4), a Th(2) cytokine, can stimulate immunoglobulin E (IgE) transcription. No previous studies evaluated the genetic mechanisms in nonatopic AA patients with elevated serum IgE. Objective. To compare serum IL-4 and total IgE levels between Egyptian nonatopic AA patients and healthy subjects and to investigate a possible relation to HLA-DRB1 alleles. Results. Serum IL-4 and total IgE were measured by ELISA in 40 controls and 54 nonatopic AA patients. Patients' HLA-DRB1 typing by sequence specific oligonucleotide probe technique was compared to normal Egyptian population. We found significantly elevated serum IL-4 and total IgE in AA patients (particularly alopecia universalis, AU, and chronic patients) (P < .01). HLA-DRB111 is a general susceptibility/chronicity allele. DRB113 is a protective allele. DRB101 and DRB107 are linked to chronicity. Localized AA showed decreased DRB103 and DRB107. Extensive forms showed increased DRB108 and decreased DRB104. Elevated IL4 and IgE were observed in patients with DRB107 and DRB111 not DRB1*04. Conclusion. Serum IL-4 and IgE are elevated in nonatopic AA patients, particularly AU and chronic disease. Relevant susceptibility, chronicity, and severity HLADRB1 alleles may have a role in determining type, magnitude, and duration of immune response in AA favouring increased IL4 and IgE.

摘要

背景。白细胞介素-4(IL-4)是一种Th2细胞因子,可刺激免疫球蛋白E(IgE)转录。以往尚无研究评估血清IgE升高的非特应性斑秃(AA)患者的遗传机制。目的。比较埃及非特应性AA患者与健康受试者的血清IL-4和总IgE水平,并研究其与HLA-DRB1等位基因的可能关系。结果。采用酶联免疫吸附测定法(ELISA)检测了40名对照者和54名非特应性AA患者的血清IL-4和总IgE。通过序列特异性寡核苷酸探针技术对患者进行HLA-DRB1分型,并与正常埃及人群进行比较。我们发现AA患者(尤其是全秃,AU,以及慢性病患者)的血清IL-4和总IgE显著升高(P <.01)。HLA-DRB111是一种普遍的易感性/慢性病等位基因。DRB113是一种保护性等位基因。DRB101和DRB107与慢性病有关。局限性AA患者的DRB103和DRB107降低。广泛性AA患者的DRB108升高而DRB104降低。在携带DRB107和DRB111而非DRB1*04的患者中观察到IL4和IgE升高。结论。非特应性AA患者的血清IL-4和IgE升高,尤其是AU和慢性病患者。相关的易感性、慢性病和严重程度HLA-DRB1等位基因可能在决定AA免疫反应的类型、强度和持续时间方面发挥作用,有利于IL4和IgE升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f2a/2910459/e5b57b340421/DRP2010-503587.001.jpg

相似文献

1
Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.
Dermatol Res Pract. 2010;2010:503587. doi: 10.1155/2010/503587. Epub 2010 Jun 30.
3
Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients.
Dermatology. 2006;213(1):12-4. doi: 10.1159/000092831.
4
Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population.
Br J Dermatol. 2011 Oct;165(4):823-7. doi: 10.1111/j.1365-2133.2011.10466.x. Epub 2011 Sep 15.
8
HLA class II alleles in patients with alopecia areata.
Eur J Dermatol. 2002 May-Jun;12(3):236-9.
10
Total serum immunoglobulin E in patients with alopecia areata.
Indian Dermatol Online J. 2014 Apr;5(2):122-7. doi: 10.4103/2229-5178.131076.

引用本文的文献

2
Correlation between increased total serum IgE levels and clinical features in alopecia areata patients.
Front Immunol. 2025 Jun 2;16:1581976. doi: 10.3389/fimmu.2025.1581976. eCollection 2025.
3
Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration.
Genes Dis. 2025 Jan 8;12(5):101518. doi: 10.1016/j.gendis.2025.101518. eCollection 2025 Sep.
7
Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata.
Biomolecules. 2023 Aug 23;13(9):1285. doi: 10.3390/biom13091285.
8
Alopecia Areata: Current Treatments and New Directions.
Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22.
9
Patch Testing in Patients With Alopecia Areata: A Case-series Study.
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022199. doi: 10.5826/dpc.1204a199. eCollection 2022 Nov.
10
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
Allergy. 2023 Apr;78(4):1047-1059. doi: 10.1111/all.15561. Epub 2022 Nov 5.

本文引用的文献

1
Human leukocyte antigen class II alleles are associated with risk of alopecia areata.
J Invest Dermatol. 2008 Jan;128(1):240-3. doi: 10.1038/sj.jid.5700973. Epub 2007 Jul 19.
4
Effects of psoralen-UV-A-Turban in alopecia areata.
Skinmed. 2006 Mar-Apr;5(2):64-8. doi: 10.1111/j.1540-9740.2006.04240.x.
5
The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
Int J Dermatol. 2002 Nov;41(11):748-53. doi: 10.1046/j.1365-4362.2002.01357.x.
6
Epidemiology and genetics of alopecia areata.
Clin Exp Dermatol. 2002 Jul;27(5):405-9. doi: 10.1046/j.1365-2230.2002.01077.x.
7
HLA class II alleles in patients with alopecia areata.
Eur J Dermatol. 2002 May-Jun;12(3):236-9.
8
Alopecia areata. Pathogenesis, diagnosis, and therapy.
Am J Clin Dermatol. 2000 Mar-Apr;1(2):101-5. doi: 10.2165/00128071-200001020-00004.
10
Regulation of B lymphocyte differentiation.
Ann Allergy Asthma Immunol. 2000 Apr;84(4):375-85; quiz 385-7. doi: 10.1016/S1081-1206(10)62267-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验